Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and
survival in patients with breast cancer, and accurate assessment of axillary LN involvement …

In 2010, EUSOMA published a position paper, describing a set of benchmark quality
indicators (QIs) that could be adopted by breast centres to allow standardised auditing and …

PURPOSE To provide recommendations on the best strategies for the management and on
the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with …

Neoadjuvant systemic therapy (NAST) provides the unique opportunity to assess response
to treatment after months rather than years of follow-up. However, significant variability exists …

Ziele Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für
Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) …

Metastatic lymph node involvement in breast cancer is a key determinant of the overall stage
of disease and prognosis. Historically, lymph node status was determined by surgery first …

Purpose This meta-analysis was designed to evaluate the utility of preoperative axillary
ultrasound combined with US-guided lymph node biopsy if indicated (AUS±biopsy), in terms …

Background Studies showed that axillary lymph node dissection can be safely omitted in
presence of positive sentinel lymph node (s) in breast cancer patients treated with breast …

Introduction Clipping and selective removal of initially suspicious axillary lymph nodes in
breast cancer patients who have been sonographically down-staged by primary systemic …

It is difficult to accurately assess axillary lymph nodes metastasis and the diagnosis of
axillary lymph nodes in patients with breast cancer is invasive and has low-sensitivity …